Preoperative chemotherapy is effective for stage III resectable non--small-cell lung cancer: metaanalysis of 16 trials.

[1]  V. Torri,et al.  Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Burdett,et al.  Pre-operative chemotherapy improves survival and reduces recurrence in operable non-small cell lung cancer: preliminary results of a systematic review and meta-analysis of individual patient data from 13 randomised trials , 2011 .

[3]  J. Padilla,et al.  Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. Lemarié,et al.  Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer. , 2010 .

[5]  J. Crowley,et al.  Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Yang Liu,et al.  Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  F. Song,et al.  Preoperative versus Postoperative Chemotherapy in Patients with Resectable Non-small Cell Lung Cancer: Systematic Review and Indirect Comparison Meta-Analysis of Randomized Trials , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  Richard J Stephens,et al.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  B. Han,et al.  [Preoperative induction chemotherapy for resectable stage IIIA non-small-cell lung cancer: a meta-analysis of 13 double-blind, randomized clinical trials.]. , 2008, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[10]  M. Kris,et al.  Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Stewart,et al.  Chemotherapy and surgery versus surgery alone in non-small cell lung cancer. , 2007, The Cochrane database of systematic reviews.

[12]  O. Dalesio,et al.  Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.

[13]  N. Kawasaki,et al.  Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis. , 2006, Lung cancer.

[14]  L. Stewart,et al.  A Systematic Review and Meta-analysis of the Literature: Chemotherapy and Surgery versus Surgery Alone in Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  J. Lafitte,et al.  Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. , 2005, Lung cancer.

[16]  G. Scagliotti.  Preliminary results of Ch.E.S.T.: A phase III study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in clinical early stages non-small cell lung cancer (NSCLC) , 2005 .

[17]  H. Pilegaard,et al.  Scandinavian phase III trial of neoadjuvant chemotherapy in NSCLC stages IB-IIIA/T3 , 2005 .

[18]  R. Ginsberg,et al.  S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results , 2005 .

[19]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[20]  B. Han,et al.  [The study of peri-operative chemotherapy in stage I-IIIa NSCLC]. , 2003, Zhonghua yi xue za zhi.

[21]  Wen Gao,et al.  [A clinicopathologic study on neoadjuvant chemotherapy in the treatment of non-small-cell lung cancer]. , 2003, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[22]  H. Kato,et al.  A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). , 2003, The Journal of thoracic and cardiovascular surgery.

[23]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[24]  Song Yu.  Clinical Evaluation of Preoperative Short-course Chemotherapy in Treatment of Stage III Non-small Cell Lung Cancer , 2003 .

[25]  B. Nathwani,et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  E. Lemarié,et al.  Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Y. Wang,et al.  [A randomized clinical trial of preoperative neoadjuvant chemotherapy followed by surgery in the treatment of stage III non-small cell lung cancer]. , 2001, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[28]  J. Padilla,et al.  Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. , 1999, Lung cancer.

[29]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[30]  J. Roth,et al.  Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1998, Lung cancer.

[31]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[32]  B. Milleron,et al.  An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer. , 1994, Seminars in oncology.

[33]  J. Roth,et al.  A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.

[34]  J. Mate,et al.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. , 1994, The New England journal of medicine.

[35]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[36]  S. Steinberg,et al.  Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. , 1992, The Annals of thoracic surgery.

[37]  J. Benichou,et al.  Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non‐small cell carcinoma results from a randomized phase II trial , 1990, Cancer.

[38]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[39]  R. Prentice,et al.  On the epidemiology of oral contraceptives and disease. , 1987, Advances in cancer research.

[40]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[41]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.